Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
Nagai N, Oike Y, Izumi-Nagai K, Urano T, Kubota Y, Noda K, Ozawa Y, Inoue M, Tsubota K, Suda T, Ishida S.
Nagai N, et al. Among authors: ishida s.
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2252-9. doi: 10.1161/01.ATV.0000240050.15321.fe. Epub 2006 Aug 3.
Arterioscler Thromb Vasc Biol. 2006.
PMID: 16888236